HCPLive Network
Latest Hospital Medicine Headlines
By Adam Hochron
As the number of people falling victim to the most recent outbreak of the Ebola Virus continues to rise past 1000, aid workers’ focus has begun to shift to preventing the spread of Ebola beyond the African continent.
By Adam Hochron
The massive media coverage of the Ebola virus outbreak in West Africa and the coordinated efforts to keep it from spreading has created fertile ground for online scammers peddling so-called Ebola treatments.
By Jeannette Wick
The issue of inappropriate antibiotic prescribing, which increases duration of treatment and hospital length of stay, is complicated in the surgical suite.
By Lee Goldberg, MBA
With the recent approval of new hepatitis C treatments, payers are increasingly concerned with controlling costs in this category through policies that may affect treatment decisions.
By Adam Hochron
The first two Americans to be treated for the Ebola virus on US soil became the first American patients to be discharged from the hospital where they had been kept in isolation for treatment from the virus.
By Catherine Kolonko
The United Kingdom’s National Institute for Health and Care Excellence (NICE) is recommending Solvaldi as a cost-effective option to treat some people who have chronic hepatitis C.
More than 40% of women undergo breast reconstruction following mastectomy and most patients are satisfied with the reconstruction decision-making process, according to a study published online Aug. 20 in JAMA Surgery.
A defined process is necessary to help physicians hire the right staff for their practice, according to an article published July 24 in Medical Economics.
By Jeanette Wick
As more pediatric surgical procedures being conducted as same-day procedures, parents are assuming responsibility for their children’s immediate post-operative pain management.
By Adam Hochron
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
Email Signup
Physician's Money Digest
Despite the assumption that larger practices provide better healthcare, a new study found smaller practices had fewer preventable hospital admissions.
Most of the stocks in the pharma and biotech space are expected to gain, but these 3 are expected to outperform the rest of the sector.